Empower Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.3M | Buy |
949,908
+34,737
| +4% | +$2.72M | 0.22% | 97 |
|
|
2025
Q1 | $66.3M | Buy |
915,171
+139,608
| +18% | +$10.1M | 0.22% | 99 |
|
|
2024
Q4 | $57.4M | Buy |
775,563
+69,685
| +10% | +$5.16M | 0.19% | 107 |
|
|
2024
Q3 | $46.6M | Buy |
705,878
+144,857
| +26% | +$9.56M | 0.16% | 112 |
|
|
2024
Q2 | $51.8M | Sell |
561,021
-9,702
| -2% | -$896K | 0.19% | 112 |
|
|
2024
Q1 | $54.5M | Buy |
570,723
+40,579
| +8% | +$3.88M | 0.2% | 110 |
|
|
2023
Q4 | $40.4M | Buy |
530,144
+65,497
| +14% | +$4.99M | 0.16% | 115 |
|
|
2023
Q3 | $32.2M | Sell |
464,647
-161,237
| -26% | -$11.2M | 0.14% | 118 |
|
|
2023
Q2 | $59M | Buy |
625,884
+13,819
| +2% | +$1.3M | 0.25% | 91 |
|
|
2023
Q1 | $50.3M | Buy |
+612,065
| New | +$50.3M | 0.23% | 106 |
|